JP Morgan Maintains Neutral on Pfizer, Lowers Price Target to $28

Benzinga Newsdesk www.benzinga.com Negative 73.9%

Neg 73.9% Neu 0% Pos 0%

JP Morgan analyst Chris Schott maintains Pfizer (NYSE:PFE) with a Neutral and lowers the price target from $30 to $28.

Comments

No comments yet. Be the first!